What is Rare Disease Day?
This year's Rare Disease Day is being celebrated on Tuesday, February 28, 2017 and it marks the tenth year that Rare Disease Day has been celebrated. On this day, thousands of organizations from around the world will hold awareness-raising activities centered on the theme of raising awareness for rare disease research.
The main objective of Rare Disease Day is to raise awareness of the need for more rare disease in the general public as well as to policy makers, public authorities, industry representatives, researchers, health professionals and anyone who has a genuine interest in rare diseases.
Learn more about Rare Disease Day.
Rare Disease Day Events
Rare Disease day is celebrated at thousands of events around the world. Click below to find an event local to you.
Veristat will be celebrating in our headquarters state of Massachusetts at the Boston Rare Disease Day 2017 event. This year's event titled Rare Disease Day 2017: Patient Involvement in Research is sponsored by MassBio, The MGH Center for Rare Neurologic Diseases, The MGH Frontotemporal Disorders Unit, member companies, patient groups, patients and legislators. Event details include:
February 28, 2017 from 11:00 AM - 12:00 PM
Massachusetts State House, Great Hall
24 Beacon Street, Boston MA US 02133
To learn more or register to attend this event, visit the Mass Bio event page at :
How Veristat Fights Rare Disease
Veristat is passionate about helping clients accelerate their rare disease therapies for unmet medical needs through the clinical development and regulatory approval process. With over 350 million rare disease sufferers worldwide today, the urgency for more treatments is paramount. Veristat is proud to have worked on over 215 rare disease treatments so far! Learn more about our rare disease experience.
Throughout the calendar year, Veristat supports numerous organizations who raise money for rare disease research. One such cause is Cycle for Survival. Earlier this month, Veristat employees raised over $25,000 to support rare cancer research. Learn more.